Doctors are looking for better ways to treat locally advanced rectal cancer, especially for patients whose tumors are harder to treat with standard methods. A review of data from 972 patients looked at how adding immunotherapy drugs, like PD-1 or PD-L1 inhibitors, changes the results when combined with different types of radiation.
The findings show that patients who received a specific type of radiation called SCRT along with immunotherapy had higher complete response rates than those who received LCRT. Specifically, the SCRT group saw a 50% complete response rate compared to 39% for the LCRT group. The study also found higher pathologic complete response rates for the SCRT group at 47% compared to 34% for the LCRT group.
While these numbers show a clear difference in how patients responded to the treatment, the study did not report on specific side effects or how well patients tolerated the drugs. These results suggest that the type of radiation used alongside immunotherapy can significantly impact how well the cancer responds to treatment.
Common questions
What is the difference between SCRT and LCRT in this study?
The study compared two types of radiation used with immunotherapy. Patients who received SCRT plus immunotherapy had a 50% complete response rate. Those who received LCRT plus immunotherapy had a 39% complete response rate. These results suggest that SCRT was more effective in achieving a complete response for these patients.
How many patients were included in this research?
The analysis included data from 972 patients who had locally advanced rectal cancer. These patients were specifically those with proficient mismatch repair or microsatellite-stable tumors. The study focused on how adding immunotherapy to their radiation and chemotherapy changed their outcomes.
What are the response rates for these treatments?
The study found a pooled complete response rate of 44% for the group receiving immunotherapy with radiation. It also found a 40% pathologic complete response rate. When looking specifically at radiation types, the SCRT group showed higher rates of both complete and pathologic complete responses compared to the LCRT group.
